Topical sulindac therapy in diabetic senile cataracts : cataract IV
Sulindac, a non-steroidal anti-inflammatory drug has been found to be a potent inhibitor of enzyme aldose reductase. We used sulindac topically in diabetic senile cataract patients to note if it effects the progression of cataracts. More of sulindac treated eyes maintained initial vision and fewer e...
Main Authors: | Sharma Y, Vajpayee R, Bhatnagar R, Mohan Madan, Azad R, Kumar Mukesh, Nath Ram |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
1989-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=1989;volume=37;issue=3;spage=127;epage=133;aulast=Sharma |
Similar Items
-
Methodology for studies on medical therapy of cataracts : cataract II
by: Sharma Y, et al.
Published: (1989-01-01) -
Topical glutathione therapy in senile cataracts Cataract III
by: Sharma Y, et al.
Published: (1989-01-01) -
Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth
by: Christopher S. Williams, et al.
Published: (1999-06-01) -
Systemic aspirin and systemic vitamin E in senile cataracts : cataract V
by: Sharma Y, et al.
Published: (1989-01-01) -
Sequelae of neglected hypermature senile cataract
by: Pranita Sahay, et al.
Published: (2019-01-01)